<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25593" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Histology, Natural Killer Cells</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rahman</surname>
            <given-names>Masum</given-names>
          </name>
          <aff>Mayo Clinic</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bordoni</surname>
            <given-names>Bruno</given-names>
          </name>
          <aff>Foundation Don Carlo Gnocchi IRCCS</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Masum Rahman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bruno Bordoni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25593.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Natural killer or NK cells are a subpopulation of large granular lymphocytes that arise from a common NK/T-cell progenitor. Accumulating evidence indicates that NK cells can develop and mature both in the bone marrow and secondary lymphoid tissues including tonsils, spleen, and lymph nodes.<xref ref-type="bibr" rid="article-25593.r1">[1]</xref>&#x000a0;In the innate immune system, NK cells participate in early cytotoxic responses against viruses, parasites, microbial pathogens, as well as tumor immunosurveillance. Also, their protective and pathogenic roles have been more defined in the development of autoimmune diseases such as systemic lupus erythematosus, type I diabetes mellitus, and autoimmune liver disease.<xref ref-type="bibr" rid="article-25593.r2">[2]</xref>&#x000a0;NK cell's function is regulated by various activating or inhibitory receptors. These germ-line encoded immunoreceptors on the surface of NK cells sense nonspecific alterations of self-cells caused by cellular stress, infections, or malignant transformation.<xref ref-type="bibr" rid="article-25593.r3">[3]</xref>&#x000a0;In contrast, B and T lymphocytes in the adaptive arm, undergo gene rearrangement to generate surface receptors and mediate the antigen-specific immune responses.<xref ref-type="bibr" rid="article-25593.r4">[4]</xref><xref ref-type="bibr" rid="article-25593.r5">[5]</xref>&#x000a0;</p>
        <p>While encountering normal cells, inhibitory receptors override activating receptors. However, molecular changes on the cell surface due to viral infection or tumor formation can stimulate the activating receptors. Upon activation, NK cells release granzyme, perforin, effector molecules of the tumor necrosis factor family, and Fas-ligand to induce apoptosis of the target cells. In addition, NK cells synthesize and release other cytokines and chemokines such as Il-10, gamma-interferon, and granulocyte-macrophage colony-stimulating factor, to recruit other immune effector cells to the target site. NK cells also exhibit antibody-dependent cell cytotoxicity against cells or target antigens which are marked with specific antibodies. Recently, therapeutic applications modulating the inhibition-activation dynamic of NK cells have been developed for multiple conditions including cancer, autoimmune disease, and diabetes.<xref ref-type="bibr" rid="article-25593.r6">[6]</xref></p>
      </sec>
      <sec id="article-25593.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Natural Killer cells represent the third lymphocyte population (Following T and B cells), and they play essential roles in the frontline's defense of the innate immune system.&#x000a0;The term natural killer suggests that these cells can kill the target cells without pre-stimulation. In contrast to other immune cells, which demand a considerable period to induce their cytolytic activity, NK cells provide ready-to-kill machinery in the immune system. These cells play various roles in several organ systems; for instance, there is emerging evidence linking NK cells with the development of autism spectrum disorder. The lower degrees of NK cell infiltration in solid tumors correlates with a favorable prognosis. In addition, excessive stimulation of NK cells promotes cell senescence in tissues, laying the foundations for aging. NK cells are important for the body's salutogenic response in dealing with various physiological and non-physiological stimuli throughout life.&#x000a0;</p>
      </sec>
      <sec id="article-25593.s3" sec-type="Structure">
        <title>Structure</title>
        <p>Morphologically, NK cells are large, granular lymphocytes that are defined by expression of CD56 and CD16 and lack the common T cell marker, CD3, and T cell receptor in humans. They constitute 5% to 15% of the total population of peripheral mononuclear circulating lymphocytes.<xref ref-type="bibr" rid="article-25593.r7">[7]</xref>&#x000a0;NK cells, dendritic cells, B, and T lymphocytes are derived from single lymphoid progenitor cells.&#x000a0;A variety of activating or inhibitory receptors have been demonstrated on the surface of NK cells as their immunoreceptor. Inhibitory receptors have cytoplasmic tyrosine-based inhibition motifs and recognize self-major histocompatibility complex class I (MHC I) molecules expressed by most of the nucleated cells. However, activating receptors recognize the ligands exhibited by pathological cells and interact with cell signaling pathways to initiate effector activities. Examples of their activating receptors are CD16, NKp30, NKp44, NKp46, NKG2C/CD94, and NKG2D/CD94. NK cells have distinct cytoplasmic granules that are structurally and functionally similar to lysosomes, hence called &#x0201c;secretory lysosomes.&#x0201d; These granules have a bi-layered membrane that separates their lytic content from the cytoplasm.<xref ref-type="bibr" rid="article-25593.r8">[8]</xref></p>
      </sec>
      <sec id="article-25593.s4" sec-type="Function">
        <title>Function</title>
        <p>Natural killer cells' effector functions are tightly regulated by the balance of inhibitory and activating receptors and downstream intracellular signaling cascades of these receptors. NK cells were originally identified in the 1970s,<xref ref-type="bibr" rid="article-25593.r9">[9]</xref><xref ref-type="bibr" rid="article-25593.r10">[10]</xref>&#x000a0;although the mechanism by which they distinguish healthy cells from virus-infected or tumor cells was not fully known for years. First, the results of research on murine NK cells demonstrated that NK cells can detect and eliminate lymphoma cells that lost the expression of MHC I, whereas MHC I-expressing tumor cells&#x000a0;are unaffected by NK cells<xref ref-type="bibr" rid="article-25593.r3">[3]</xref>. This led to the idea of missing self in the activation of NK cells, particularly in their anti-tumor activity. In physiological conditions, most of the circulating NK cells are resting as their inhibitory receptors interact with MHC I in the healthy cells, and this accounts for exhibiting self-tolerance. Almost every healthy cell expresses MHC I molecules, a potential ligand for inhibitory NK cell receptors,&#x000a0; However, MHC I molecules are downregulated upon viral infection and tumor transformation (missing self), exerting subthreshold inhibitory signaling to the NK cells, moving their balance toward the activated state.</p>
        <p>In addition, upregulation of NK cells activating receptors occurs in stressed or damaged cells resulting in targeting these cells for the cytolytic activity of NK cells.&#x000a0;Interaction between CD16 on NK cells with antigens expressed on tumor cells causes&#x000a0;antibody-dependent&#x000a0;cell-mediated&#x000a0;cytotoxicity tumor cell lysis by NK cells.<xref ref-type="bibr" rid="article-25593.r11">[11]</xref><xref ref-type="bibr" rid="article-25593.r12">[12]</xref><xref ref-type="bibr" rid="article-25593.r13">[13]</xref><xref ref-type="bibr" rid="article-25593.r14">[14]</xref><xref ref-type="bibr" rid="article-25593.r15">[15]</xref>&#x000a0;NK cells can kill tumor cells without previous sensitization. They directly kill tumor cells by releasing lytic granules that contain granzyme and perforin. NK cells, together with cytotoxic CD8+ T lymphocytes, generate immunity against virus-infected and tumor cells. In most circumstances, tumor cells downregulate their MHC I to escape from cytotoxic T cells. However, the lower expression of MHC I makes tumor cells susceptible to lysis by NK cells.<xref ref-type="bibr" rid="article-25593.r16">[16]</xref></p>
      </sec>
      <sec id="article-25593.s5" sec-type="Histochemistry and Cytochemistry">
        <title>Histochemistry and Cytochemistry</title>
        <p>NK cells are considered the equivalent of CD8-positive T lymphocytes in the innate immune system and multiple cell markers are used for their characterization in immunocytochemistry staining. Natural killer cells are usually classified as CD3 negative and CD56 positive cells and subdivided into CD56dim and CD56bright groups. CD56dim and CD56bright subsets are defined based on the density of CD56 and have distinct functional attributes. About 90% of circulating and spleen natural killer cells are CD56dim, CD16 positive, and express perforin. CD56dim cells mainly perform a cytotoxic action and CD16 mediates ADCC. In comparison, NK cells in lymph nodes and peripheral lymphoid organs (eg, tonsils) are CD56bright and CD16 negative. CD56 bright cells are mainly cytokine-secreting cells and can produce several cytokines, including IFN-&#x003b3; (gamma-interferon) upon stimulation.<xref ref-type="bibr" rid="article-25593.r16">[16]</xref><xref ref-type="bibr" rid="article-25593.r17">[17]</xref><xref ref-type="bibr" rid="article-25593.r18">[18]</xref></p>
      </sec>
      <sec id="article-25593.s6" sec-type="Microscopy, Light&#x0000d;&#x0000a;">
        <title>Microscopy, Light
</title>
        <p>Natural killer cells present a distinct group of circulating lymphocytes on the peripheral blood smear. On Wright-Giemsa-staining, they are visible as large granular lymphocyte morphology. They possess large nuclei containing coarse chromatin and prominent nuclei. Their abundant basophilic cytoplasm contains plenty of azurophilic granules that are negative for peroxidase staining.<xref ref-type="bibr" rid="article-25593.r19">[19]</xref></p>
      </sec>
      <sec id="article-25593.s7" sec-type="Microscopy, Electron&#x0000d;&#x0000a;">
        <title>Microscopy, Electron
</title>
        <p>NK cells are large and exhibit various shapes and express microvilli more prominently in the area of effector-to-target contact. At the same time, microvilli are scant cell surfaces in the absence of target cells. Membranes are not extensively fused in the region of target and effector cell contact. NK cells have structurally distinct granules that consist of two different compartments. The outer compartment includes the lysosome-associated phosphatase acid enzymes and trimetaphosphatase. No enzymatic activities associated with the inner compartment have been identified. At the time of degranulation, a limited area of the cytoplasm exhibits vacuole-like areas possessing granules and apparent granular debris. Degranulation appears to be implicated in NK cells' cytotoxic activity. Convoluted nuclei with distinctive polarity against the dense granules and pseudopodia are typical. In the cytoplasm, both Mitochondria and polysomes are observed.<xref ref-type="bibr" rid="article-25593.r19">[19]</xref><xref ref-type="bibr" rid="article-25593.r20">[20]</xref></p>
      </sec>
      <sec id="article-25593.s8" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In addition to NK cell roles in defense against viral infections and tumor immunosurveillance, they have been linked to several other diseases including asthma&#x000a0;<xref ref-type="bibr" rid="article-25593.r21">[21]</xref>, inflammatory bowel disease&#x000a0;<xref ref-type="bibr" rid="article-25593.r22">[22]</xref>,&#x000a0;and autoimmune diseases&#x000a0;<xref ref-type="bibr" rid="article-25593.r23">[23]</xref>. Advancements in understanding the pathophysiology of NK cells resulted in the development of new therapeutic options and treatments. For instance, NK cells are found in the pancreas of patients with diabetes type I, and they enhance the disease development. Reducing the NK cell activation using specific blocking antibodies will prevent further disease progression.<xref ref-type="bibr" rid="article-25593.r6">[6]</xref></p>
      </sec>
      <sec id="article-25593.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>NK cells are essential components of innate immunity. Although their function may be compromised in many primary immune deficiency disorders, rare isolated Natural Killer cell deficiency syndromes may also occur. There are two potential varieties of NK cell deficiency: (1) the classical natural killer cell deficiency (CNKD) and (2) functional natural killer cell deficiency (FNKD).<xref ref-type="bibr" rid="article-25593.r24">[24]</xref><xref ref-type="bibr" rid="article-25593.r25">[25]</xref>&#x000a0;CNKD reflects the significant absence of NK cells among peripheral blood mononuclear cells and fewer than 1% of NK cells in peripheral blood should be present in a minimum of three independent tests separated by one month to establish this diagnosis. Unlike CNKD, patients with FNKD have NK cells found in their peripheral blood within the spectrum of age-specific average values; however, permanently deficient in their functions. Both CNKD and FNKD patients are highly susceptible to human papillomavirus, herpes simplex virus, cytomegalovirus, Epstein-Barr virus, varicella-zoster virus infection.<xref ref-type="bibr" rid="article-25593.r24">[24]</xref><xref ref-type="bibr" rid="article-25593.r26">[26]</xref><xref ref-type="bibr" rid="article-25593.r27">[27]</xref></p>
        <p>The prognostic value of NK cells infiltrating solid tumors has attracted considerable attention in clinical practice. Several independent studies have demonstrated that higher levels of NK cell markers such as CD56 and NKp46 in solid tumors correlate with favorable prognosis and overall survival rate.<xref ref-type="bibr" rid="article-25593.r28">[28]</xref><xref ref-type="bibr" rid="article-25593.r29">[29]</xref><xref ref-type="bibr" rid="article-25593.r30">[30]</xref>&#x000a0;However, further research is necessary to establish a scoring system including information from tumor type, clinical staging, pathological grading, etc. The clinical development of NK cell-based cancer therapy provided promising results. The NK cell-based clinical trials presented a desirable safety profile and efficacy in hematologic malignancies and solid tumors.<xref ref-type="bibr" rid="article-25593.r31">[31]</xref><xref ref-type="bibr" rid="article-25593.r32">[32]</xref><xref ref-type="bibr" rid="article-25593.r33">[33]</xref></p>
      </sec>
      <sec id="article-25593.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25593&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25593">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25593/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25593">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25593.s11">
        <title>References</title>
        <ref id="article-25593.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scoville</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Freud</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Caligiuri</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells.</article-title>
            <source>Front Immunol</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>360</fpage>
            <pub-id pub-id-type="pmid">28396671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>NK Cells in Autoimmune Diseases: Protective or Pathogenic?</article-title>
            <source>Front Immunol</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>624687</fpage>
            <pub-id pub-id-type="pmid">33777006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sivori</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vacca</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Del Zotto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Munari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mingari</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Moretta</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.</article-title>
            <source>Cell Mol Immunol</source>
            <year>2019</year>
            <month>May</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>430</fpage>
            <page-range>430-441</page-range>
            <pub-id pub-id-type="pmid">30778167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carrillo-Bustamante</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ke&#x0015f;mir</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>de Boer</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The evolution of natural killer cell receptors.</article-title>
            <source>Immunogenetics</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>68</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-18</page-range>
            <pub-id pub-id-type="pmid">26392015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oshimi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.</article-title>
            <source>Intern Med</source>
            <year>2017</year>
            <volume>56</volume>
            <issue>14</issue>
            <fpage>1759</fpage>
            <page-range>1759-1769</page-range>
            <pub-id pub-id-type="pmid">28717070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Viswanathan</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Natural killer cells: In health and disease.</article-title>
            <source>Hematol Oncol Stem Cell Ther</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>47</fpage>
            <page-range>47-55</page-range>
            <pub-id pub-id-type="pmid">25571788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lal</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy.</article-title>
            <source>Front Immunol</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>1124</fpage>
            <pub-id pub-id-type="pmid">28955340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krzewski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Coligan</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Human NK cell lytic granules and regulation of their exocytosis.</article-title>
            <source>Front Immunol</source>
            <year>2012</year>
            <volume>3</volume>
            <fpage>335</fpage>
            <pub-id pub-id-type="pmid">23162553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kiessling</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Petranyi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>K&#x000e4;rre</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jondal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tracey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wigzell</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems.</article-title>
            <source>J Exp Med</source>
            <year>1976</year>
            <month>Apr</month>
            <day>01</day>
            <volume>143</volume>
            <issue>4</issue>
            <fpage>772</fpage>
            <page-range>772-80</page-range>
            <pub-id pub-id-type="pmid">1082915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herberman</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Bartram</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Haskill</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Nunn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holden</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Fc receptors on mouse effector cells mediating natural cytotoxicity against tumor cells.</article-title>
            <source>J Immunol</source>
            <year>1977</year>
            <month>Jul</month>
            <volume>119</volume>
            <issue>1</issue>
            <fpage>322</fpage>
            <page-range>322-6</page-range>
            <pub-id pub-id-type="pmid">326962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abel</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thakar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Malarkannan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Natural Killer Cells: Development, Maturation, and Clinical Utilization.</article-title>
            <source>Front Immunol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>1869</fpage>
            <pub-id pub-id-type="pmid">30150991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The Development and Diversity of ILCs, NK Cells and Their Relevance in Health and Diseases.</article-title>
            <source>Adv Exp Med Biol</source>
            <year>2017</year>
            <volume>1024</volume>
            <fpage>225</fpage>
            <page-range>225-244</page-range>
            <pub-id pub-id-type="pmid">28921473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stabile</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fionda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gismondi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santoni</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Role of Distinct Natural Killer Cell Subsets in Anticancer Response.</article-title>
            <source>Front Immunol</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>293</fpage>
            <pub-id pub-id-type="pmid">28360915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lo Nigro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Macagno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sangiolo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bertolaccini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Aglietta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Merlano</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives.</article-title>
            <source>Ann Transl Med</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>105</fpage>
            <pub-id pub-id-type="pmid">31019955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Keam</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Doh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Heo</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines.</article-title>
            <source>J Immunother Cancer</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">32830112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sojka</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yokoyama</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Uterine Natural Killer Cells.</article-title>
            <source>Front Immunol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>960</fpage>
            <pub-id pub-id-type="pmid">31118936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuchs</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>ILC1s in Tissue Inflammation and Infection.</article-title>
            <source>Front Immunol</source>
            <year>2016</year>
            <volume>7</volume>
            <fpage>104</fpage>
            <pub-id pub-id-type="pmid">27047491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Th&#x000e9;r&#x000e9;sine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andr&#x000e8;s</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hentges</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zimmer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>CD56bright natural killer (NK) cells: an important NK cell subset.</article-title>
            <source>Immunology</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>126</volume>
            <issue>4</issue>
            <fpage>458</fpage>
            <page-range>458-65</page-range>
            <pub-id pub-id-type="pmid">19278419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsuchiyama</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yoshino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kondoh</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Oka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Akagi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hiraki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nakayama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shibuya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawabata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harada</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.</article-title>
            <source>Blood</source>
            <year>1998</year>
            <month>Aug</month>
            <day>15</day>
            <volume>92</volume>
            <issue>4</issue>
            <fpage>1374</fpage>
            <page-range>1374-83</page-range>
            <pub-id pub-id-type="pmid">9694726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frey</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Petty</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>McConnell</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Electron microscopic study of natural killer cell-tumor cell conjugates.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1982</year>
            <month>Sep</month>
            <volume>79</volume>
            <issue>17</issue>
            <fpage>5317</fpage>
            <page-range>5317-21</page-range>
            <pub-id pub-id-type="pmid">6291036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ple</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barrier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Amniai</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marquillies</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bertout</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tsicopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Walzer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lassalle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Duez</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Natural killer cells accumulate in lung-draining lymph nodes and regulate airway eosinophilia in a murine model of asthma.</article-title>
            <source>Scand J Immunol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>72</volume>
            <issue>2</issue>
            <fpage>118</fpage>
            <page-range>118-27</page-range>
            <pub-id pub-id-type="pmid">20618770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yadav</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Potential role of NK cells in the pathogenesis of inflammatory bowel disease.</article-title>
            <source>J Biomed Biotechnol</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>348530</fpage>
            <pub-id pub-id-type="pmid">21687547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kucuksezer</surname>
                <given-names>UC</given-names>
              </name>
              <name>
                <surname>Aktas Cetin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Esen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tahrali</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Akdeniz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gelmez</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Deniz</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The Role of Natural Killer Cells in Autoimmune Diseases.</article-title>
            <source>Front Immunol</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>622306</fpage>
            <pub-id pub-id-type="pmid">33717125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orange</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Natural killer cell deficiency.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>3</issue>
            <fpage>515</fpage>
            <page-range>515-525</page-range>
            <pub-id pub-id-type="pmid">23993353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orange</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>How I Manage Natural Killer Cell Deficiency.</article-title>
            <source>J Clin Immunol</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-23</page-range>
            <pub-id pub-id-type="pmid">31754930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ornstein</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Geurs</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Natural killer cell functional defects in pediatric patients with severe and recurrent herpesvirus infections.</article-title>
            <source>J Infect Dis</source>
            <year>2013</year>
            <month>Feb</month>
            <day>01</day>
            <volume>207</volume>
            <issue>3</issue>
            <fpage>458</fpage>
            <page-range>458-68</page-range>
            <pub-id pub-id-type="pmid">23175766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almerigogna</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fassio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Giudizi</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Biagiotti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Manuelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chiappini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Galli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Romagnani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Martino</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Natural killer cell deficiencies in a consecutive series of children with herpetic encephalitis.</article-title>
            <source>Int J Immunopathol Pharmacol</source>
            <year>2011</year>
            <season>Jan-Mar</season>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>231</fpage>
            <page-range>231-8</page-range>
            <pub-id pub-id-type="pmid">21496407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lv</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.</article-title>
            <source>Front Immunol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>1242</fpage>
            <pub-id pub-id-type="pmid">32714321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wittekindt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reuschenbach</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hennig</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thevarajah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>W&#x000fc;rdemann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Prigge</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>von Knebel Doeberitz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dreyer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gattenl&#x000f6;hner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Klussmann</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.</article-title>
            <source>Int J Cancer</source>
            <year>2016</year>
            <month>May</month>
            <day>01</day>
            <volume>138</volume>
            <issue>9</issue>
            <fpage>2263</fpage>
            <page-range>2263-73</page-range>
            <pub-id pub-id-type="pmid">26662627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ascierto</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Idowu</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Khalak</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Dumur</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Bedognetti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tomei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ascierto</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Shanker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bear</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marincola</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>De Maria</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manjili</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients.</article-title>
            <source>J Transl Med</source>
            <year>2013</year>
            <month>Jun</month>
            <day>12</day>
            <volume>11</volume>
            <fpage>145</fpage>
            <pub-id pub-id-type="pmid">23758773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Galat</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Galat</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YKA</given-names>
              </name>
              <name>
                <surname>Wainwright</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>NK cell-based cancer immunotherapy: from basic biology to clinical development.</article-title>
            <source>J Hematol Oncol</source>
            <year>2021</year>
            <month>Jan</month>
            <day>06</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <pub-id pub-id-type="pmid">33407739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Macapinlac</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Basar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nassif Kerbauy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Overman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thall</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nandivada</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nunez Cortes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Daher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hosing</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Kebriaei</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Neelapu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nieto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wierda</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Keating</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Champlin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shpall</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Rezvani</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.</article-title>
            <source>N Engl J Med</source>
            <year>2020</year>
            <month>Feb</month>
            <day>06</day>
            <volume>382</volume>
            <issue>6</issue>
            <fpage>545</fpage>
            <page-range>545-553</page-range>
            <pub-id pub-id-type="pmid">32023374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25593.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Del Zotto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marcenaro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vacca</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sivori</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pende</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Della Chiesa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moretta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ingegnere</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mingari</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Moretta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moretta</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Markers and function of human NK cells in normal and pathological conditions.</article-title>
            <source>Cytometry B Clin Cytom</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>100</fpage>
            <page-range>100-114</page-range>
            <pub-id pub-id-type="pmid">28054442</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
